compounded semaglutide crackdown news today FDA on off-brand Ozempic products set to take effect, threatening supply and access for many The FDA's GLP-1 Compounding Crackdown

The patent expiry opens the segment to more than 40 expected generic manufacturers, marking the start of price competition in a category that has so far seen limited adoption due to high costs

Retatrutide may become the first effective pharmaceutical treatment for this condition

Human Error & Handling Risks Common failures include leaving GLP-1 stock at room temperature during transfers or storing it in domestic fridges

One of the best ways to keep these issues in check

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

Zepbound, by contrast, requires extra steps before Aetna will approve it